Rituximab in the management of chronic immune thrombocytopenic purpura: an effective and safe therapeutic alternative in refractory patients
F. J. Peñalver, V. Jimenez-Yuste, M. Almagro, A. Alvarez-Larrán, L. Rodríguez, M. Casado, L. Gallur, P. Giraldo, R. Hernández, D. Menor, M. J. Rodríguez, D. Caballero, R. González, J. Mayans, I. MilláVolume:
85
Pages:
1
DOI:
10.1007/s00277-006-0123-3
Date:
August, 2006
File:
PDF, 48 KB
2006